The goal of this clinical trial is - Comparison of Empagliflozin - Linagliptin with Empagliflozin - Metformin combination therapy in reduction of body weight in T2DM Patients and it included 200 diabetic subjects with total study period of 12 weeks and individual study period of 4 weeks .
Age range
40 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Overall improvement in Fasting Blood Glucose
Timeframe: 12 weeks
Overall change in Body Mass Index ( kg/m2)
Timeframe: 12 weeks
Overall improvement in Random Blood Glucose
Timeframe: 12 weeks
Over all improvement in Glycated Hemoglobin ( HbA1c)
Timeframe: 12 weeks
Overall change in Waist to Hip Ratio
Timeframe: 12 weeks
Overall change in Waist Circumference
Timeframe: 12 weeks